The safety of amodiaquine use in pregnant women
- 30 October 2007
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 6 (6) , 631-635
- https://doi.org/10.1517/14740338.6.6.631
Abstract
(2007). The safety of amodiaquine use in pregnant women. Expert Opinion on Drug Safety: Vol. 6, No. 6, pp. 631-635. doi: 10.1517/14740338.6.6.631Keywords
This publication has 34 references indexed in Scilit:
- Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in SenegalMalaria Journal, 2007
- Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in MadagascarMalaria Journal, 2007
- Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'ZérékoréMalaria Journal, 2007
- A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malariaTropical Medicine & International Health, 2005
- A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in GhanaTropical Medicine & International Health, 2005
- Therapy of Falciparum Malaria in Sub-Saharan Africa: from Molecule to PolicyClinical Microbiology Reviews, 2004
- Antimalarial compounds: from bench to bedsideJournal of Experimental Biology, 2003
- Malaria during pregnancy: A priority area of malaria research and controlParasitology Today, 1995
- Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents.BMJ, 1986
- FREQUENCY OF SEVERE NEUTROPENIA ASSOCIATED WITH AMODIAQUINE PROPHYLAXIS AGAINST MALARIAThe Lancet, 1986